Vol 12, No 9 (September 30, 2023): Translational Andrology and Urology

Editorial

Is the AGREE II framework the appropriate tool to evaluate global urolithiasis guidelines?
Venkat M. Ramakrishnan, Kendrick Yim, Daniel A. Wollin
Translational Andrology and Urology  
2023;
12
(9)
:1366-1367
.
Redefining surveillance strategies: innovations in testicular cancer care
Julian Chavarriaga, Rashid K. Sayyid, Rui Bernardino, Ravi Kumar, Majed Al-Rumayyan, Robert J. Hamilton
Translational Andrology and Urology  
2023;
12
(9)
:1368-1370
.
Active surveillance: minimising treatment while maximising outcomes in testis cancer
Ciara Conduit, Ben Tran
Translational Andrology and Urology  
2023;
12
(9)
:1371-1374
.

Original Article

Benefits of accurate and guided endoureterotomy versus ureteral balloon dilatation in the management of ureteral strictures—comparative animal study
Muñoz Guillermo Victoria, Fernández Aparicio Tomás, Sánchez-Margallo Francisco Miguel, Soria Federico
Translational Andrology and Urology  
2023;
12
(9)
:1375-1382
.
Understanding the prevalence and distribution of fellowship trained female and male genitourinary reconstruction and men’s health/andrology academic faculty in the United States
Mei N. Tuong, Hamilton P. Lombard, Bradley A. Erickson
Translational Andrology and Urology  
2023;
12
(9)
:1383-1389
.
Assessment of neophallus length following metoidioplasty
Hannah Glick, Michael Tang, Stephanie Daignault-Newton, Miriam Hadj-Moussa
Translational Andrology and Urology  
2023;
12
(9)
:1390-1396
.
Clinical and molecular features of 40 Chinese patients with idiopathic hypogonadotropic hypogonadism
Yuanfan Wang, Weijun Jiang, Xinyi Xia
Translational Andrology and Urology  
2023;
12
(9)
:1397-1407
.
Application of the decisional regret scale (DRS) in men undergoing anti-incontinence procedures for stress urinary incontinence
Alayna Dunbar, Jonathan Heinlen, Gennady Slobodov, Bhalaajee Meenakshi-Sundaram, James Furr
Translational Andrology and Urology  
2023;
12
(9)
:1408-1415
.
Clinical outcomes of immune checkpoint inhibitor plus nab-paclitaxel in metastatic upper tract urothelial carcinoma
Ruopeng Su, Zeyu Chen, Hailong Hu, Shuai Jiang, Minfeng Chen, Qiong Chen, Paul Thomas Gellhaus, Antonio Augusto Ornellas, Davide Campobasso, Qiang Wei, Jiwei Huang, Yige Bao, Wei Xue
Translational Andrology and Urology  
2023;
12
(9)
:1416-1425
.

Review Article

The impact of cognitive impairment in urologic implants: a narrative review
Darren J. Bryk, Jacqueline Zillioux, Emmett H. Kennady, Fionna Sun, William Hasken, Nicolas M. Ortiz, David E. Rapp, Ryan P. Smith
Translational Andrology and Urology  
2023;
12
(9)
:1426-1438
.
Adjuvant intraluminal therapies for upper tract urothelial carcinoma
Raymond Khargi, Christopher Connors, Anna Ricapito, Alan J. Yaghoubian, Blair E. Gallante, Johnathan A. Khusid, William M. Atallah, Mantu Gupta
Translational Andrology and Urology  
2023;
12
(9)
:1439-1448
.
Advances in chemoablation in upper tract urothelial carcinoma: overview of indications and treatment patterns
Josh Gottlieb, Jennifer Linehan, Katie S. Murray
Translational Andrology and Urology  
2023;
12
(9)
:1449-1455
.
Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma
Andrew J. Zganjar, David D. Thiel, Timothy D. Lyon
Translational Andrology and Urology  
2023;
12
(9)
:1456-1468
.
Application of the single-port robotic platform during radical nephroureterectomy for upper tract urothelial carcinoma: feasibility of the single-port robot in the multi-quadrant setting
Antony A. Pellegrino, Mahmoud Mima, Simone Crivellaro
Translational Andrology and Urology  
2023;
12
(9)
:1469-1474
.